Skin Solutions

Uneven skin tone in 2026 is understood as the interaction of three factors: pigmentation, vascular redness, and skin barrier quality. Clinical data shows that visible tone irregularity is often caused...

Acne and post-acne marks are biologically different conditions that require different treatment strategies. Active acne is driven by inflammation, bacteria, excess sebum, and clogged follicles, while post-acne marks involve pigmentation...

Modern hyperpigmentation is increasingly viewed as a multi-layer process involving inflammation, pigment transfer, and skin barrier integrity rather than excess melanin alone. Ingredients such as Tranexamic Acid, Niacinamide, Vitamin C...

By 2026, Tranexamic Acid (TXA) and Niacinamide are viewed as complementary rather than competing ingredients for hyperpigmentation. TXA primarily reduces inflammation-related pigment signalling, while Niacinamide regulates melanosome transfer and strengthens...

According to the 2026 clinical approach, Tranexamic Acid and Vitamin C are no longer viewed as competing brightening ingredients but as complementary control layers in pigmentation management. Tranexamic Acid mainly...

According to the 2026 clinical perspective, dark spot fading is no longer viewed as a simple bleaching process but as a gradual stabilization of inflammation and barrier function. OEM laboratory...